Regeneron Pharmaceuticals and Sanofi have won FDA expanded approval of their blockbuster anti-inflammatory drug Dupixent in chronic obstructive pulmonary disease.
Related Posts
Kevin Plank Broke Under Armour. Can He Fix It?
The CEO said the brand has suffered from executive turnover and strategy shifts, but more than half a dozen former executives said he was responsible […]
Auto & Transport Roundup: Market Talk
Read about UPS, Spirit Airlines, Norwegian Air and more in the latest Market Talks covering the Auto and Transport sector.
Travelers Upbeat on Momentum Despite Fires as Fourth-Quarter Profit Surges
- staff
- January 22, 2025
- 0
The property-and-casualty insurer said the strong results and outlook would allow it to support customers affected by the wildfires that devastated L.A.